FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/12/099597 [Registered on: 22/12/2025] Trial Registered Prospectively
Last Modified On: 21/12/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Homeopathy 
Study Design  Single Arm Study 
Public Title of Study   Effectiveness Of Individualised Homoeopathic Medicine In Females With Fibromyalgia 
Scientific Title of Study   A Prospective Interventional Study: Effectiveness Of Individualised Homoeopathic Medicine In Females Of 30-60 Years Of Age With Fibromyalgia Assessed By Fibromyalgia Impact Questionnaire-Revised (FIQ-R) 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Jammalamadugu Damini 
Designation  Pg Scholar 
Affiliation  JIMS Homoeopathic Medical College and Hospital 
Address  JIMS Homoeopathic Medical College and Hospital Sriramnagar Muchintal Hyderabad Telengana 509325 India
OPD 6 Department Of Practice Of Medicine JIMS Homoeopathic Medical College and Hospital Sriramnagar Muchintal Hyderabad Telengana 509325 India
Hyderabad
TELANGANA
509325
India 
Phone  9391493825  
Fax    
Email  jdaminisudarshan@gmail.com  
 
Details of Contact Person
Scientific Query  
Name  Dr Vibhavya S 
Designation  Professor 
Affiliation  JIMS Homoeopathic Medical College and Hospital 
Address  OPD 6 Department Of Practice Of Medicine JIMS Homoeopathic Medical College and Hospital Hyderabad Telengana 509325 India
OPD 6 Depatment Of Practice Of Medicine JIMS Homoeopathic Medical College and Hospital Hyderabad Telengana 509325 India
Hyderabad
TELANGANA
509325
India 
Phone  9391493825  
Fax    
Email  vibhavya.shetty@gmail.com  
 
Details of Contact Person
Public Query  
Name  Dr Jammalamadugu Damini 
Designation  Pg Scholar 
Affiliation  JIMS Homoeopathic Medical College and Hospital 
Address  OPD 6 Depatment Of Practice Of Medicine JIMS Homoeopathic Medical College and Hospital Hyderabad Telengana 509325 India
OPD 6 Depatment Of Practice Of Medicine JIMS Homoeopathic Medical College and Hospital Hyderabad Telengana 509325 India
Hyderabad
TELANGANA
509325
India 
Phone  9391493825  
Fax    
Email  jdaminisudarshan@gmail.com  
 
Source of Monetary or Material Support  
NIL 
 
Primary Sponsor  
Name  JIMS Homoeopathic Medical College and Hospital 
Address  JIMS Homoeopathic Medical College and Hospital Sriramnagar Muchintal Hyderabad Telangana 509325 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Jammalamadugu Damini  JIMS Homoeopathic Medical College and Hospital  OPD 6 Department Of Practice Of Medicine JIMS Homoeopathic Medical College and Hospital Sriramnagar Muchintal Hyderabad Telangana
Hyderabad
TELANGANA 		 9391493825

jdaminisudarshan@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
IECJIMS  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: M797||Fibromyalgia,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Individualised Homoeopathic Medicine  Medicines Will Be Prescribed Based On The Selected Similimum From The Repertory With Each Dose Consisting Of 4 Pills Of Size No 20 Potency Selection And Repetition Of Doses Will Be Determined According To The Patients Susceptibility With Treatment Duration Typically Spanning 4 Weeks Involving Initial Daily or Biweekly Doses Followed By Spacing Based On Response Until Symptom Resolution 
Comparator Agent  NIL  NIL 
 
Inclusion Criteria  
Age From  30.00 Year(s)
Age To  60.00 Year(s)
Gender  Female 
Details  Fulfilling ACR 2016 Criteria For Fibromyalgia 
 
ExclusionCriteria 
Details  Moderate And Severe Depressive Disorder Patients Assessed By Psychiatrist Using The Hamilton Depression Rating Scale
Current Use Of Corticosteroids Or Immunosuppressants
Other Autoimmune Disorders
Pregnant Women and Lactating Mothers
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
To Assess The Change In FIQ-R (Fibromyalgia Impact Questionnaire – Revised) Scores After Administration Of Individualized Homoeopathic Medicine Over a Period of 6 Months In Females Aged 30-60 Years Diagnosed With Fibromyalgia  To Assess The Change In FIQ-R (Fibromyalgia Impact Questionnaire – Revised) Scores After Administration Of Individualized Homoeopathic Medicine Over a Period of 6 Months At Baseline And At 6 Month In Females Aged 30-60 Years Diagnosed With Fibromyalgia 
 
Secondary Outcome  
Outcome  TimePoints 
NIL  NIL 
 
Target Sample Size   Total Sample Size="36"
Sample Size from India="36" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   16/01/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="2"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Fibromyalgia is a chronic, multi-system pain disorder characterized by widespread musculoskeletal pain, fatigue, sleep disturbances, and impaired quality of life. Conventional treatment often provides incomplete relief, highlighting the need for integrative and individualized therapeutic approaches. This prospective interventional study aims to evaluate the effectiveness of individualized Homoeopathic medicine in females aged 30–60 years diagnosed with fibromyalgia, using the Revised Fibromyalgia Impact Questionnaire (FIQ-R) as the primary outcome measure. Eligible participants will be recruited based on ACR diagnostic criteria and assessed for miasmatic background and totality of symptoms. Individualized prescriptions will be administered according to Hahnemannian principles, with follow-ups at defined intervals over a 16-week period. Pre- and post-intervention scores of FIQ-R, along with secondary parameters such as sleep quality, tenderness, and functional capacity, will be statistically analyzed. The study seeks to determine whether individualized Homoeopathic treatment produces significant improvement in symptom severity and quality of life. Findings may contribute evidence toward the role of Homoeopathy as a supportive and individualized modality in fibromyalgia management. 
Close